An FMI-laboratory in 1978
An FMI-laboratory in 1978 April 8, 2020 On April 8, 1970, the founding charter of the FMI was signed. For 50 years, the FMI has stayed true to its initial mission: To promote basic research in the fields of biochemistry and medicine, and to train young scientists. Today, with over 340 associates, the Basel-based research institute is a worldwide leader in the fields of neurobiology, epigenetics and quantitative biology. The FMI was founded by Ciba AG and J.R. Geigy AG - two Basel-based pharmaceutical companies that would merge and grow to become Novartis in 1996. Their common goal was to bridge the gap between high level academic research and the pharmaceutical industry. The new joint institute was given the freedom to pursue open-ended biological research, but was asked to interact with company scientists so that new discoveries could influence pharmaceutical development - a novel and visionary step at the time. The institute was named after Friedrich Miescher, the Basel biochemist who discovered nucleic acids in 1869, 100 years before the institute was founded.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
